Endpoint definition
↥Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
Extra metadata
No definition available.
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
Extra metadata
List of similar endpoints to Special screening examination for infectious and parasitic diseases based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
None
All | Female | Male | |
---|---|---|---|
Number of individuals | 7935 | 4752 | 3183 |
Unadjusted prevalence (%) | 3.05 | 3.23 | 2.81 |
Mean age at first event (years) | 32.93 | 30.28 | 36.89 |
Follow-up | Absolute risk | HR [95% CI] | p | N |
---|---|---|---|---|
1998–2019 | 0.03 | 2.24 [1.25, 4.02] | 6.9e-3 | 106 |
15 years | 0.02 | 2.97 [1.85, 4.78] | 6.9e-6 | 92 |
5 years | 0.00 | 4.07 [2.47, 6.70] | 3.6e-8 | 27 |
1 year | - | - | - | - |
Index endpoint: Z21_SPECIAL_SCREEN_EXAM_INFECTIOUS_PARASITIC_DISEA – Special screening examination for infectious and parasitic diseases
GWS hits: 0
before Special screening examination for infectious and parasitic diseases
after Special screening examination for infectious and parasitic diseases
Loading survival analyses plot
Loading survival analyses table